We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBI icon
2551
MBIA
MBI
$266M
$8.78M ﹤0.01%
798,600
-6,838
-0.8% -$68.1K
AUY
2552
DELISTED
Yamana Gold, Inc.
AUY
$8.77M ﹤0.01%
2,099,770
+186,386
+10% +$903K
AVO icon
2553
Mission Produce
AVO
$1.13B
$8.75M ﹤0.01%
422,730
+269,294
+176% +$5.51M
KDNY
2554
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$8.74M ﹤0.01%
618,706
+172,669
+39% +$2.76M
VNET
2555
VNET Group
VNET
$2.04B
$8.73M ﹤0.01%
383,054
+46,937
+14% +$1.2M
DYN icon
2556
Dyne Therapeutics
DYN
$4.71B
$8.72M ﹤0.01%
414,647
+123,751
+43% +$2.33M
VAPO
2557
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$8.7M ﹤0.01%
45,979
+4,966
+12% +$846K
VSEC icon
2558
VSE Corp
VSEC
$5.81B
$8.69M ﹤0.01%
175,545
+12,610
+8% +$579K
MCS icon
2559
Marcus Corp
MCS
$946M
$8.67M ﹤0.01%
408,908
+32,054
+9% +$666K
ATRO icon
2560
Astronics
ATRO
$3.51B
$8.67M ﹤0.01%
594,218
+15,087
+3% +$219K
FRO icon
2561
Frontline
FRO
$8.88B
$8.66M ﹤0.01%
962,054
+26,696
+3% +$215K
RFP
2562
DELISTED
Resolute Forest Products Inc.
RFP
$8.66M ﹤0.01%
709,635
+4,543
+0.6% +$63.6K
CVI icon
2563
CVR Energy
CVI
$3.31B
$8.64M ﹤0.01%
481,395
+7,198
+2% +$149K
OOMA icon
2564
Ooma
OOMA
$590M
$8.64M ﹤0.01%
458,078
+54,690
+14% +$991K
SIEN
2565
DELISTED
Sientra, Inc.
SIEN
$8.63M ﹤0.01%
108,472
+3,408
+3% +$242K
EGRX
2566
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$8.62M ﹤0.01%
201,458
+15,311
+8% +$632K
BCAB icon
2567
BioAtla
BCAB
$5.41M
$8.62M ﹤0.01%
4,067
+168
+4% +$380K
AROW icon
2568
Arrow Financial
AROW
$667M
$8.58M ﹤0.01%
260,924
+24,541
+10% +$805K
WSBF icon
2569
Waterstone Financial
WSBF
$375M
$8.55M ﹤0.01%
434,821
-4,615
-1% -$92.8K
STEL
2570
DELISTED
Stellar Bancorp
STEL
$8.53M ﹤0.01%
312,518
+6,699
+2% +$202K
MOV icon
2571
Movado Group
MOV
$866M
$8.53M ﹤0.01%
271,106
+4,575
+2% +$139K
STXS icon
2572
Stereotaxis
STXS
$133M
$8.52M ﹤0.01%
883,997
+52,531
+6% +$415K
KLRS
2573
Kalaris Therapeutics
KLRS
$96.4M
$8.52M ﹤0.01%
18,764
+173
+0.9% +$89.3K
LORL
2574
DELISTED
Loral Space and Communications, Inc.
LORL
$8.51M ﹤0.01%
219,131
+4,243
+2% +$161K
RCEL icon
2575
Avita Medical
RCEL
$142M
$8.51M ﹤0.01%
414,673
+218,101
+111% +$4.3M

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.